1. Home
  2. ASTC vs INBS Comparison

ASTC vs INBS Comparison

Compare ASTC & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astrotech Corporation (DE)

ASTC

Astrotech Corporation (DE)

HOLD

Current Price

$19.20

Market Cap

4.9M

Sector

Industrials

ML Signal

HOLD

INBS

Intelligent Bio Solutions Inc.

HOLD

Current Price

$2.37

Market Cap

5.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTC
INBS
Founded
1984
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
5.7M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
ASTC
INBS
Price
$19.20
$2.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.8M
113.4K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
2600.00
68.65
EPS
0.25
N/A
Revenue
$1,000,000.00
$1,980,484.00
Revenue This Year
N/A
$778.48
Revenue Next Year
N/A
N/A
P/E Ratio
$106.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.92
$0.54
52 Week High
$68.85
$24.90

Technical Indicators

Market Signals
Indicator
ASTC
INBS
Relative Strength Index (RSI) 49.21 40.66
Support Level $3.17 $2.31
Resistance Level $68.85 $3.16
Average True Range (ATR) 12.62 0.17
MACD -1.32 -0.02
Stochastic Oscillator 25.07 28.21

Price Performance

Historical Comparison
ASTC
INBS

About ASTC Astrotech Corporation (DE)

Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.

Share on Social Networks: